The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 10, 2022

Filed:

Dec. 12, 2016
Applicants:

Zhejiang Jiuzhou Pharmaceutical Co., Ltd., Taizhou, CN;

Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, CN;

Inventors:

Kuiling Ding, Shanghai, CN;

Yuxi Cao, Shanghai, CN;

Zhiyao Zheng, Shanghai, CN;

Qinglei Chong, Shanghai, CN;

Zheng Wang, Shanghai, CN;

Assignee:

Other;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 13/72 (2006.01); B01J 31/22 (2006.01); C07C 39/17 (2006.01); C07C 43/21 (2006.01); C07C 43/225 (2006.01); C07F 9/6571 (2006.01); C07B 53/00 (2006.01); C07C 231/12 (2006.01); C07C 233/51 (2006.01);
U.S. Cl.
CPC ...
C07C 13/72 (2013.01); B01J 31/22 (2013.01); C07B 53/00 (2013.01); C07C 39/17 (2013.01); C07C 43/21 (2013.01); C07C 43/225 (2013.01); C07C 231/12 (2013.01); C07C 233/51 (2013.01); C07F 9/6571 (2013.01);
Abstract

Chiral spirobiindane skeleton compound and preparation method thereof is disclosed in the present invention. The spirobiindane skeleton compound of the present invention having the structure formula of I or I'; the preparation method for synthesizing the spirobiindane skeleton compound of the present invention comprising the following steps: in the presence of solvent and catalysts, the structure formula compound III reacted through intramolecular Friedel-Crafts reaction to obtain the compound of formula I; the catalyst is a Browsteric acidor Lewis acid. The preparation method of chiral fused spirobiindane skeleton compound of the present invention does not need to adopt chiral starting materials or chiral resolving agents, does not require chiral resolving steps, is simple in method, is simple in post-treatment, and is economic and environment friendly. High product yield, high product optical purity and chemical purity. The catalyst for the asymmetric reaction is obtained from the chiral spirobiindane skeleton ligand of the present invention, under the catalytic reagent of transition metal, the catalyzed hydrogenation reaction can arrive at a remarkable catalytic effect with a product yield of >99%, and a product ee value of up to >99%.


Find Patent Forward Citations

Loading…